2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.
Many chronic hepatitis C virus (HCV)-infected patients with current therapy do not clear the virus. It is necessary to find novel treatments. The effect of 2-octynoic acid (2-OA) on HCV infection in human hepatocytes was examined. The mechanism of 2-OA antiviral activity was explored. Our data showe...
Päätekijät: | Darong Yang, Binbin Xue, Xiaohong Wang, Xiaoyan Yu, Nianli Liu, Yimin Gao, Chen Liu, Haizhen Zhu |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Public Library of Science (PLoS)
2013-01-01
|
Sarja: | PLoS ONE |
Linkit: | http://europepmc.org/articles/PMC3669134?pdf=render |
Samankaltaisia teoksia
-
Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
Tekijä: Yimin Gao, et al.
Julkaistu: (2014-01-01) -
MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.
Tekijä: Darong Yang, et al.
Julkaistu: (2014-01-01) -
Innate host response in primary human hepatocytes with hepatitis C virus infection.
Tekijä: Darong Yang, et al.
Julkaistu: (2011-01-01) -
Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase
Tekijä: Ben Zhou, et al.
Julkaistu: (2021-10-01) -
AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis.
Tekijä: Theresa S Moser, et al.
Julkaistu: (2012-01-01)